Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
8.87B | 8.42B | 7.99B | 7.42B | 7.06B | Gross Profit |
2.78B | 2.73B | 2.68B | 2.41B | 2.35B | EBIT |
274.46M | 333.72M | 296.12M | 149.03M | 118.25M | EBITDA |
623.33M | 668.83M | 645.61M | 492.14M | 454.16M | Net Income Common Stockholders |
268.75M | 263.13M | 259.57M | 141.06M | 142.04M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
529.69M | 650.70M | 606.74M | 764.18M | 1.13B | Total Assets |
7.52B | 7.40B | 7.46B | 7.57B | 8.03B | Total Debt |
1.58B | 1.78B | 1.98B | 2.23B | 2.83B | Net Debt |
1.05B | 1.13B | 1.38B | 1.47B | 1.71B | Total Liabilities |
3.38B | 3.49B | 3.78B | 4.12B | 4.68B | Stockholders Equity |
4.14B | 3.91B | 3.68B | 3.45B | 3.35B |
Cash Flow | Free Cash Flow | |||
136.41M | 396.95M | 207.97M | 367.55M | 458.84M | Operating Cash Flow |
325.10M | 537.51M | 367.75M | 560.33M | 571.10M | Investing Cash Flow |
-203.26M | -260.97M | -245.65M | -292.09M | -186.81M | Financing Cash Flow |
-242.84M | -232.58M | -279.55M | -628.46M | -265.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥2.12B | 7.90 | 2.04% | 5.32% | 2.13% | ||
62 Neutral | $6.76B | 11.07 | 2.80% | 6.34% | 2.68% | -24.87% | |
€676.14M | 13.47 | 6.22% | 4.33% | ― | ― | ||
74 Outperform | ¥39.89B | 19.53 | 0.27% | 24.11% | 22.03% | ||
70 Outperform | ¥23.83B | 10.31 | 4.43% | 11.38% | 10.56% | ||
58 Neutral | ¥62.56B | 13.79 | 2.16% | -1.42% | -58.51% | ||
47 Neutral | ¥4.14B | 262.06 | 2.35% | -2.66% | -4452.83% |